Optimal approach to prevent CMV disease
ContributorsPosfay Barbe, Klara
Published inPediatric transplantation, vol. 12, no. 4, p. 385-388
Publication date2008
Keywords
- Child
- Clinical Trials as Topic
- Cytokines/metabolism
- Cytomegalovirus Infections/prevention & control
- Ganciclovir/therapeutic use
- Humans
- Immunosuppressive Agents/therapeutic use
- Organ Transplantation/methods
- Treatment Outcome
- Viral Load
NoteComment on: Renoult E, Clermont MJ, Phan V, Buteau C, Alfieri C, Tapiero B. Prevention of CMV disease in pediatric kidney transplant recipients: evaluation of pp67 NASBA-based pre-emptive ganciclovir therapy combined with CMV hyperimmune globulin prophylaxis in high-risk patients. Pediatr Transplant. 2008 Jun;12(4):385-8
Affiliation entities
Citation (ISO format)
POSFAY BARBE, Klara. Optimal approach to prevent CMV disease. In: Pediatric transplantation, 2008, vol. 12, n° 4, p. 385–388. doi: 10.1111/j.1399-3046.2008.00907.x
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:2531
- DOI : 10.1111/j.1399-3046.2008.00907.x
- PMID : 18282209
Journal ISSN1397-3142
